Epirubicin Hydrochloride (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the Epirubicin Hydrochloride drug offered from Sagent Pharmaceuticals. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
| NON-PROPRIETARY NAME: | epirubicin hydrochloride |
| SUBSTANCE NAME: | EPIRUBICIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-08-31 |
| END MARKETING DATE: | 0000-00-00 |
Epirubicin Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Epirubicin Hydrochloride from Sagent Pharmaceuticals |
| LABELER NAME: | Sagent Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/mL) |
| START MARKETING DATE: | 2014-08-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25021-203_8b4d4db3-8a78-4b4f-a5c3-bacb101395a0 |
| PRODUCT NDC: | 25021-203 |
| APPLICATION NUMBER: | ANDA065361 |
Other EPIRUBICIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
